Back to search

Article

A liquid biopsy-centered, pan-cancer, open next generation sequencing panel to support clinical decision-making (LION panel)

2026-06-08

Abstract excerpt

Cancer treatment has shifted toward personalized therapy based on molecular profiling, particularly in advanced disease. Existing circulating tumor DNA panels are often broad, generating many non-actionable variants and incurring costs that limit routine use in molecular tumor boards. We developed and validated a manufacturer-independent, 109-gene liquid biopsy-centered pan-cancer open next generation sequencing p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d6008c2b-5518-5eda-bc87-3f60808a36d9
DOI
10.64898/2026.06.05.26354976
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A liquid biopsy-centered, pan-cancer, open next generation sequencing panel to support clinical decision-making (LION panel)DOI 10.64898/2026.06.05.26354976
Analytical Performance Evaluation of a 523-Gene Circulating Tumor DNA Assay for Next-Generation Sequencing-Based Comprehensive Tumor Profiling in Liquid Biopsy Samples.Semantic proximity
Implementation of a 1021-gene liquid biopsy assay for real-world tumor genomic profiling in oncology practice.Semantic proximity
Development and Performance Validation of a Comprehensive Liquid Biopsy Genotyping Panel for Pan-cancer Analysis.Semantic proximity
A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency.Semantic proximity
Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based Methodologies.Semantic proximity
Liquid biopsies across the cancer care continuum.Semantic proximity
Liquid Biopsy Hotspot Variant Assays: Analytical Validation for Application in Residual Disease Detection and Treatment Monitoring.Semantic proximity
Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications.Semantic proximity
Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer PatientsSemantic proximity
Circulating tumor DNA precision oncology enables effective and sensitive molecular diagnostics and actionable target detection in pediatric solid tumors - the INFORM experienceSemantic proximity
Molecular profiling for precision cancer therapiesSemantic proximity
Signed in Blood: Circulating Tumor DNA in Cancer Diagnosis, Treatment and ScreeningSemantic proximity
Select a neighboring publication to make it the new centre.